Fig. 2From: Urinary alpha-1 antitrypsin and CD59 glycoprotein predict albuminuria development in hypertensive patients under chronic renin-angiotensin system suppressionCD59 (1a, 2a), AAT (1b, 2b) and TNA (1c, 2c) urinary response in healthy and hypertensive patients chronically RAS suppressed at different stages of albuminuria progression. Graphs show normalized peak area from SRM-LC-MS/MS data. ROC curves evaluate response to albuminuria condition (CD59 and AAT) or hypertension (TNA)Back to article page